Skip to content

Clinical trials

Completed Genital Neoplasms, Male trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genital Neoplasms, Male Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20082
20092
20113
20131
20141
20151
20172
20181
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Steba Biotech S.A.5
Advanced Accelerator Applications1
Aragon Pharmaceuticals, Inc.1
Dendreon1
Institut Claudius Regaud1
NanOlogy, LLC1
Novartis Pharmaceuticals1
Sharp HealthCare1
Tampere University Hospital1
Tesaro, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genital Neoplasms, Male16
Prostatic Neoplasms15
Urogenital Neoplasms14
Prostatic Diseases12
Neoplasms10
Genital Diseases, Male8
Neoplasms by Site7
Carcinoma6
Male Urogenital Diseases5
Genital Diseases2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.